| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of fatal intoxication due to the new designer drug 25B-NBOMe
|
Yoshida, Ken-ichi
|
|
2015
|
33 |
2 |
p. 396-401
|
artikel
|
| 2 |
AH-7921: the list of new psychoactive opioids is expanded
|
Katselou, Maria
|
|
2015
|
33 |
2 |
p. 195-201
|
artikel
|
| 3 |
A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products
|
Uchiyama, Nahoko
|
|
2015
|
33 |
2 |
p. 367-373
|
artikel
|
| 4 |
A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products
|
Uchiyama, Nahoko
|
|
2015
|
33 |
2 |
p. 244-259
|
artikel
|
| 5 |
Cannabinoid disposition in oral fluid after controlled vaporizer administration with and without alcohol
|
Hartman, Rebecca L.
|
|
2015
|
33 |
2 |
p. 260-278
|
artikel
|
| 6 |
Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites
|
Huppertz, Laura M.
|
|
2015
|
33 |
2 |
p. 388-395
|
artikel
|
| 7 |
Comprehensive review of the detection methods for synthetic cannabinoids and cathinones
|
Namera, Akira
|
|
2015
|
33 |
2 |
p. 175-194
|
artikel
|
| 8 |
Development and validation of a liquid chromatography–mass spectrometry procedure after solid-phase extraction for detection of 19 doping peptides in human urine
|
Mazzarino, Monica
|
|
2015
|
33 |
2 |
p. 321-337
|
artikel
|
| 9 |
Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography–chemical ionization-tandem mass spectrometry
|
Negishi, Shoko
|
|
2015
|
33 |
2 |
p. 338-347
|
artikel
|
| 10 |
Diphenidine and its metabolites in blood and urine analyzed by MALDI-Q-TOF mass spectrometry
|
Minakata, Kayoko
|
|
2015
|
33 |
2 |
p. 402-408
|
artikel
|
| 11 |
Evaluation of the neurochemical effects of methoxetamine using brain microdialysis in mice
|
Fuchigami, Yuki
|
|
2015
|
33 |
2 |
p. 374-379
|
artikel
|
| 12 |
Identification and quantification of 4′-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC–TOF-MS in an autopsy case
|
Shintani-Ishida, Kaori
|
|
2015
|
33 |
2 |
p. 348-354
|
artikel
|
| 13 |
Identification and quantitation of 5-fluoro-ADB-PINACA and MAB-CHMINACA in dubious herbal products
|
Wurita, Amin
|
|
2015
|
33 |
2 |
p. 213-220
|
artikel
|
| 14 |
Identification and quantitation of mifepristone and its N-demethyl metabolite in the plasma of an aborted fetus by liquid chromatography–quadrupole–time-of-flight–mass spectrometry (LC–Q–TOFMS) and ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS–MS)
|
Ishii, Akira
|
|
2015
|
33 |
2 |
p. 409-412
|
artikel
|
| 15 |
Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry
|
Castaneto, Marisol S.
|
|
2015
|
33 |
2 |
p. 295-310
|
artikel
|
| 16 |
Identification of analogs of LY2183240 and the LY2183240 2′-isomer in herbal products
|
Asada, Akiko
|
|
2015
|
33 |
2 |
p. 311-320
|
artikel
|
| 17 |
Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver
|
Hasegawa, Koutaro
|
|
2015
|
33 |
2 |
p. 380-387
|
artikel
|
| 18 |
Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry
|
Ellefsen, Kayla N.
|
|
2015
|
33 |
2 |
p. 202-212
|
artikel
|
| 19 |
Simultaneous plasma and oral fluid morphine and codeine concentrations after controlled administration of poppy seeds with known opiate content
|
Newmeyer, Matthew N.
|
|
2015
|
33 |
2 |
p. 235-243
|
artikel
|
| 20 |
Simultaneous quantification of 37 synthetic cannabinoid metabolites in human urine by liquid chromatography-tandem mass spectrometry
|
Jang, Moonhee
|
|
2015
|
33 |
2 |
p. 221-234
|
artikel
|
| 21 |
Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues
|
Banister, Samuel D.
|
|
2015
|
33 |
2 |
p. 355-366
|
artikel
|
| 22 |
Urinary excretion and metabolism of the α-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans
|
Shima, Noriaki
|
|
2015
|
33 |
2 |
p. 279-294
|
artikel
|
Tijdschrift beschrijving